Maciejewska J, Jankowski M, Zegarska B, Czajkowski R. Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2014;31(3):194-196. doi:10.5114/pdia.2014.40796.
APA
Maciejewska, J., Jankowski, M., Zegarska, B., & Czajkowski, R. (2014). Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 31(3), 194-196. https://doi.org/10.5114/pdia.2014.40796
Chicago
Maciejewska, Jolanta, Marek Jankowski, Barbara Zegarska, and Rafał Czajkowski. 2014. "Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 31 (3): 194-196. doi:10.5114/pdia.2014.40796.
Harvard
Maciejewska, J., Jankowski, M., Zegarska, B., and Czajkowski, R. (2014). Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 31(3), pp.194-196. https://doi.org/10.5114/pdia.2014.40796
MLA
Maciejewska, Jolanta et al. "Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 31, no. 3, 2014, pp. 194-196. doi:10.5114/pdia.2014.40796.
Vancouver
Maciejewska J, Jankowski M, Zegarska B, Czajkowski R. Case reportStevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2014;31(3):194-196. doi:10.5114/pdia.2014.40796.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous, unpredictable, life-threatening drug side reactions. A very rare case of norfloxacin-induced SJS/TEN overlap with uncommon clinical presentation in a patient with a suspected urinary tract infection is reported. The SJS/TEN management with possible treatment capabilities are discussed. In spite of only two previous reports of norfloxacin-induced SJS and TEN we believe that awareness of norfloxacin adverse reactions needs to be raised among prescribers.
